Familial Genetic Cancer Risk Assessment with respect to a Silent BRCA2 mutation

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The study authors would like to thank all participants who consented to participate in this study. We also acknowledge Bajaj Auto Ltd. for providing support to research activities at PCCM (Grant #PCCM529)

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

DCGI/CDSCO Registration Number: ECR/298/Indt/MH/2018 (dated May 14 2018) The study was approved by the Institutional Ethics Committee of PCCM (DCGI/CDSCO Registration Number: ECR/298/Indt/MH/2018. Every participant gave a separate informed consent for the use of their personal and medical information associated with this study. The study follows principles of the declaration of Helsinki (Brazil, 2013 version) and National Ethics Guidelines 2017 issued by the Indian Council of Medical Research, Government of India. Ethics Committee Approval available on request.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes